Therefore, high fiber diets (Ma et al., 2006) and pharmacological interventions to target cardiovascular risk factors such as novel anticoagulants, lipid lowering agents, beta-adrenoreceptor antagonists, and angiotensin converting enzyme (ACE) inhibitors (Prasad, 2006) are important adjunctive treatments to consider for people with schizophrenia. Here, ACE is linked to schizophrenia.